arrow
Return

Phage Therapy Faces Evolutionary Challenges

delete2018-06-12
delete79
delete
OA
AI
C
Clara Torres‐Barceló *
DOI:10.3390/v10060323delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Antibiotic resistance evolution in bacteria indicates that one of the challenges faced by phage therapy is that, sooner or later, bacteria will evolve resistance to phages. Evidently, this is the case of every known antimicrobial therapy, but here this is also part of a ubiquitous natural process of co-evolution between phages and bacteria. Fundamental evolutionary studies hold some clues that are crucial to limit the problematic process of bacterial resistance during phage applications. First, I discuss here the importance of defining evolutionary and ecological factors influencing bacterial resistance and phage counter-defense mechanisms. Then, I comment on the interest of determining the co-evolutionary dynamics between phages and bacteria that may allow for selecting the conditions that will increase the probability of therapeutic success. I go on to suggest the varied strategies that may ensure the long-term success of phage therapy, including analysis of internal phage parameters and personalized treatments. In practical terms, these types of approaches will define evolutionary criteria regarding how to develop, and when to apply, therapeutic phage cocktails. Integrating this perspective in antimicrobial treatments, such as phage therapy, is among the necessary steps to expand its use in the near future, and to ensure its durability and success.
Keywords:
phage therapy
evolution
bacterial resistance
virulence
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Viruses cover
Viruses
IF:
3.5
Papers:
1.7W
Citations:
4.9W

Organization

U
University of La Reunion
Scholars:
1.7K
Papers: 1.1K
Citations: 1
Cited Papers

Cited Papers

Bacteriophage adhering to mucus provide a non-host-derived immunity
err2013-05-20
err708
errOAAI
errBarr, Jeremy J.; Auro, Rita; Furlan, Mike; Whiteson, Katrine L.; Erb, Marcella L.; Pogliano, Joe; Stotland, Aleksandr; Wolkowicz, Roland; Cutting, Andrew S.; Doran, Kelly S.; Salamon, Peter; Youle, Merry; Rohwer, Forest
errShare
errSave
Host-parasite coevolutionary arms races give way to fluctuating selection
err2011-04-27
err233
PREAI
errHall, Alex R.; Scanlan, Pauline D.; Morgan, Andrew D.; Buckling, Angus
errShare
errSave
Markets vs. polls as election predictors: An historical assessment
err2012-09-01
err0
PREAI
errRobert S. Erikson; Christopher Wlezien
errShare
errSave
Long-term genomic coevolution of host-parasite interaction in the natural environment
err2017-07-24
err89
errOAAI
errLaanto, Elina; Hoikkala, Ville; Ravantti, Janne; Sundberg, Lotta-Riina
errShare
errSave
Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains
err2018-04-05
err148
errOAAI
errRohde, Christine; Resch, Gregory; Pirnay, Jean-Paul; Blasdel, Bob G.; Debarbieux, Laurent; Gelman, Daniel; Gorski, Andrzej; Hazan, Ronen; Huys, Isabelle; Kakabadze, Elene; Lobocka, Malgorzata; Maestri, Alice; de Freitas Almeida, Gabriel Magno; Makalatia, Khatuna; Malik, Danish J.; Maslanova, Ivana; Merabishvili, Maia; Pantucek, Roman; Rose, Thomas; Stverakova, Dana; Van Raemdonck, Hilde; Verbeken, Gilbert; Chanishvili, Nina
errShare
errSave
Expression of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma and the Surrounding Liver and Correlation with MRI Findings
err2005-03-01
err0
PREAI
errMasayuki Kanematsu; Shinji Osada; Nozomi Amaoka; Satoshi Goshima; Hiroshi Kondo; Hiroki Kato; Hironori Nishibori; Ryujiro Yokoyama; Hiroaki Hoshi; Noriyuki Moriyama
errShare
errSave
researcher View more